Cargando…

Evaluation of different diagnostic modalities of minimal hepatic encephalopathy in cirrhotic patients: case-control study

INTRODUCTION: Minimal hepatic encephalopathy (MHE) represents one of the most overlooked complications of liver cirrhosis. AIM OF THE STUDY: To compare the utility and efficacy of different MHE diagnostic modalities. MATERIAL AND METHODS: This case-control study was conducted on hepatitis C virus (H...

Descripción completa

Detalles Bibliográficos
Autores principales: Salman, Tary, Elsabaawy, Maha, Omar, Mahmoud, Afify, Mohamed, Elezawy, Hossam, Ghanem, Samar, Abdelraouf, Osama, Rewisha, Eman, Shebl, Nashwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527340/
https://www.ncbi.nlm.nih.gov/pubmed/34712834
http://dx.doi.org/10.5114/ceh.2021.109292
_version_ 1784586055651950592
author Salman, Tary
Elsabaawy, Maha
Omar, Mahmoud
Afify, Mohamed
Elezawy, Hossam
Ghanem, Samar
Abdelraouf, Osama
Rewisha, Eman
Shebl, Nashwa
author_facet Salman, Tary
Elsabaawy, Maha
Omar, Mahmoud
Afify, Mohamed
Elezawy, Hossam
Ghanem, Samar
Abdelraouf, Osama
Rewisha, Eman
Shebl, Nashwa
author_sort Salman, Tary
collection PubMed
description INTRODUCTION: Minimal hepatic encephalopathy (MHE) represents one of the most overlooked complications of liver cirrhosis. AIM OF THE STUDY: To compare the utility and efficacy of different MHE diagnostic modalities. MATERIAL AND METHODS: This case-control study was conducted on hepatitis C virus (HCV)-related compensated cirrhotic patients. The Psychometric Hepatic Encephalopathy Score (PHES) was used to assign patients to MHE and controls. All patients were subjected to plasma ammonia, serum 3-nitrotyrosine (3-NT), critical flicker frequency (CFF), and the modified inhibitory control test (ICT). RESULTS: CFF was significantly lower in the control group (38.5, 40 Hz, p = 0.003). The unweighted lures on ICT were 8.7, 4.9 in MHE and controls (p < 0.001). Moreover, ammonia was higher in the MHE group (89, 61.5 µmol/l, p < 0.001). 3-NT was also higher in the MHE group (31.5, 13.7 nmol/l, p < 0.001) respectively. CFF at cutoff < 39 Hz had sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of 57.5%, 77.5%, 71.9% and 64.6%, respectively; in modified ICT, at cutoff > 5 unweighted lures the values were 87.5%, 80%, 81.4% and 86.5%, respectively; in ammonia, at cutoff ≥ 76.45 µmol/l the values were 65%, 72.5%, 70.3% and 67.4%, respectively; for 3-NT at cutoff ≥ 14.15 nmol/l the values were 85%, 82.5%, 82.9% and 84.6%, respectively. The accuracy for MHE diagnosis was 67.5%, 83.3%, 68.8%, 83.8% relying on CFF, 3-NT, ammonia, and ICT respectively. On multivariate analysis, CFF < 39 Hz (OR = 10.2, p = 0.04), modified ICT > 5 unweighted lures (OR = 43.2, p = 0.002), and serum 3-NT levels ≥ 14.15 nmol/l (OR = 50.4, p < 0.001) were independent predictors of MHE. CONCLUSIONS: 3-NT and ICT are advantageous to reveal MHE in compensated liver cirrhosis, while CFF can be only used as adjuncts, with humble merits of ammonia.
format Online
Article
Text
id pubmed-8527340
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-85273402021-10-27 Evaluation of different diagnostic modalities of minimal hepatic encephalopathy in cirrhotic patients: case-control study Salman, Tary Elsabaawy, Maha Omar, Mahmoud Afify, Mohamed Elezawy, Hossam Ghanem, Samar Abdelraouf, Osama Rewisha, Eman Shebl, Nashwa Clin Exp Hepatol Original Paper INTRODUCTION: Minimal hepatic encephalopathy (MHE) represents one of the most overlooked complications of liver cirrhosis. AIM OF THE STUDY: To compare the utility and efficacy of different MHE diagnostic modalities. MATERIAL AND METHODS: This case-control study was conducted on hepatitis C virus (HCV)-related compensated cirrhotic patients. The Psychometric Hepatic Encephalopathy Score (PHES) was used to assign patients to MHE and controls. All patients were subjected to plasma ammonia, serum 3-nitrotyrosine (3-NT), critical flicker frequency (CFF), and the modified inhibitory control test (ICT). RESULTS: CFF was significantly lower in the control group (38.5, 40 Hz, p = 0.003). The unweighted lures on ICT were 8.7, 4.9 in MHE and controls (p < 0.001). Moreover, ammonia was higher in the MHE group (89, 61.5 µmol/l, p < 0.001). 3-NT was also higher in the MHE group (31.5, 13.7 nmol/l, p < 0.001) respectively. CFF at cutoff < 39 Hz had sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of 57.5%, 77.5%, 71.9% and 64.6%, respectively; in modified ICT, at cutoff > 5 unweighted lures the values were 87.5%, 80%, 81.4% and 86.5%, respectively; in ammonia, at cutoff ≥ 76.45 µmol/l the values were 65%, 72.5%, 70.3% and 67.4%, respectively; for 3-NT at cutoff ≥ 14.15 nmol/l the values were 85%, 82.5%, 82.9% and 84.6%, respectively. The accuracy for MHE diagnosis was 67.5%, 83.3%, 68.8%, 83.8% relying on CFF, 3-NT, ammonia, and ICT respectively. On multivariate analysis, CFF < 39 Hz (OR = 10.2, p = 0.04), modified ICT > 5 unweighted lures (OR = 43.2, p = 0.002), and serum 3-NT levels ≥ 14.15 nmol/l (OR = 50.4, p < 0.001) were independent predictors of MHE. CONCLUSIONS: 3-NT and ICT are advantageous to reveal MHE in compensated liver cirrhosis, while CFF can be only used as adjuncts, with humble merits of ammonia. Termedia Publishing House 2021-09-23 2021-09 /pmc/articles/PMC8527340/ /pubmed/34712834 http://dx.doi.org/10.5114/ceh.2021.109292 Text en Copyright © 2021 Clinical and Experimental Hepatology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/) )
spellingShingle Original Paper
Salman, Tary
Elsabaawy, Maha
Omar, Mahmoud
Afify, Mohamed
Elezawy, Hossam
Ghanem, Samar
Abdelraouf, Osama
Rewisha, Eman
Shebl, Nashwa
Evaluation of different diagnostic modalities of minimal hepatic encephalopathy in cirrhotic patients: case-control study
title Evaluation of different diagnostic modalities of minimal hepatic encephalopathy in cirrhotic patients: case-control study
title_full Evaluation of different diagnostic modalities of minimal hepatic encephalopathy in cirrhotic patients: case-control study
title_fullStr Evaluation of different diagnostic modalities of minimal hepatic encephalopathy in cirrhotic patients: case-control study
title_full_unstemmed Evaluation of different diagnostic modalities of minimal hepatic encephalopathy in cirrhotic patients: case-control study
title_short Evaluation of different diagnostic modalities of minimal hepatic encephalopathy in cirrhotic patients: case-control study
title_sort evaluation of different diagnostic modalities of minimal hepatic encephalopathy in cirrhotic patients: case-control study
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527340/
https://www.ncbi.nlm.nih.gov/pubmed/34712834
http://dx.doi.org/10.5114/ceh.2021.109292
work_keys_str_mv AT salmantary evaluationofdifferentdiagnosticmodalitiesofminimalhepaticencephalopathyincirrhoticpatientscasecontrolstudy
AT elsabaawymaha evaluationofdifferentdiagnosticmodalitiesofminimalhepaticencephalopathyincirrhoticpatientscasecontrolstudy
AT omarmahmoud evaluationofdifferentdiagnosticmodalitiesofminimalhepaticencephalopathyincirrhoticpatientscasecontrolstudy
AT afifymohamed evaluationofdifferentdiagnosticmodalitiesofminimalhepaticencephalopathyincirrhoticpatientscasecontrolstudy
AT elezawyhossam evaluationofdifferentdiagnosticmodalitiesofminimalhepaticencephalopathyincirrhoticpatientscasecontrolstudy
AT ghanemsamar evaluationofdifferentdiagnosticmodalitiesofminimalhepaticencephalopathyincirrhoticpatientscasecontrolstudy
AT abdelraoufosama evaluationofdifferentdiagnosticmodalitiesofminimalhepaticencephalopathyincirrhoticpatientscasecontrolstudy
AT rewishaeman evaluationofdifferentdiagnosticmodalitiesofminimalhepaticencephalopathyincirrhoticpatientscasecontrolstudy
AT sheblnashwa evaluationofdifferentdiagnosticmodalitiesofminimalhepaticencephalopathyincirrhoticpatientscasecontrolstudy